113 related articles for article (PubMed ID: 8854026)
21. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
22. The determination of phosphorus in Haemophilus influenzae type b conjugate vaccines by inductively coupled plasma-atomic emission spectrometry.
Swartz LA; Progar JJ; May JC
Biologicals; 2000 Dec; 28(4):227-31. PubMed ID: 11237358
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
24. Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines.
Bolgiano B; Mawas F; Yost SE; Crane DT; Lemercinier X; Corbel MJ
Vaccine; 2001 Apr; 19(23-24):3189-200. PubMed ID: 11312015
[TBL] [Abstract][Full Text] [Related]
25. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
Eskola J; Takala AK; Käyhty H
Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627
[TBL] [Abstract][Full Text] [Related]
26. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
27. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
28. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
Goldblatt D; Richmond P; Millard E; Thornton C; Miller E
J Infect Dis; 1999 Aug; 180(2):538-41. PubMed ID: 10395878
[TBL] [Abstract][Full Text] [Related]
29. Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
Plumb JE; Yost SE
Vaccine; 1996 Apr; 14(5):399-404. PubMed ID: 8735551
[TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
[TBL] [Abstract][Full Text] [Related]
31. Fighting Haemophilus influenzae type b.
Isaacs D
Aust Fam Physician; 1993 Oct; 22(10):1886. PubMed ID: 8280020
[No Abstract] [Full Text] [Related]
32. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
[TBL] [Abstract][Full Text] [Related]
33. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine.
Forleo-Neto E; de Oliveira CF; Maluf EM; Bataglin C; Araujo JM; Kunz LF; Pustai AK; Vieira VS; Zanella RC; Brandileone MC; Mimica LM; Mimica IM
J Infect Dis; 1999 Oct; 180(4):1153-8. PubMed ID: 10479142
[TBL] [Abstract][Full Text] [Related]
34. A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines.
von Hunolstein C; Parisi L; Recchia S
Vaccine; 1999 Jan; 17(2):118-25. PubMed ID: 9987145
[TBL] [Abstract][Full Text] [Related]
35. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl.
Lei QP; Lamb DH; Heller R; Pietrobon P
J Pharm Biomed Anal; 2000 Jan; 21(6):1087-91. PubMed ID: 10708393
[TBL] [Abstract][Full Text] [Related]
36. New methods for the characterisation of biopharmaceuticals: conjugate vaccines against Haemophilus influenzae type b.
Lemercinier X; Crane D; Gee C; Austin S; Bolgiano B; Jones C
Dev Biol Stand; 1999; 101():177-83. PubMed ID: 10566791
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
Lehmann D; Kakazo M; Yarsley S; Javati A; Taime J; Saleu G; Namuigi P; Alpers MP; Mendelman PM; Staub T
P N G Med J; 1998; 41(3-4):102-11. PubMed ID: 10934551
[TBL] [Abstract][Full Text] [Related]
38. A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations.
Saydam M; Rigsby P; Mawas F
Biologicals; 2014 Jan; 42(1):29-33. PubMed ID: 24200313
[TBL] [Abstract][Full Text] [Related]
39. Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid.
Laferriere C; Ravenscroft N; Wilson S; Combrink J; Gordon L; Petre J
Glycoconj J; 2011 Oct; 28(7):463-72. PubMed ID: 21850577
[TBL] [Abstract][Full Text] [Related]
40. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
